Soy Isoflavones, CYP1A1, CYP1B1, and COMT Polymorphisms, and Breast Cancer: A Case–Control Study in Southwestern China

Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis

(2010) Konstantinos P. Economopoulos et al.   BREAST CANCER RESEARCH AND TREATMENT

COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case–control studies

(2010) Haixia Ding et al.   BREAST CANCER RESEARCH AND TREATMENT

Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies

(2010) Jia-Yi Dong et al.   BREAST CANCER RESEARCH AND TREATMENT

Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women’s Health Study

(2009) Sang-Ah Lee et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls

(2009) Chen Mao et al.   BREAST CANCER RESEARCH AND TREATMENT

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects

(2009) Lei Yao et al.   BREAST CANCER RESEARCH AND TREATMENT

Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis

(2009) Theodoros N. Sergentanis et al.   BREAST CANCER RESEARCH AND TREATMENT

Isoflavone-deprived soy peptide suppresses mammary tumorigenesis by inducing apoptosis

(2009) Kyoungsook Park et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Epidemiology of soy exposures and breast cancer risk

(2008) A H Wu et al.   BRITISH JOURNAL OF CANCER

Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells

(2008) Leane Lehmann et al.   CARCINOGENESIS